Your NEJM Group Today: Dismantling Racism & Inequity in Health Care / Ticagrelor vs. Clopidogrel / Onc/Hem & OB/GYN Opportunities

By the Editors

Take a look at today's highlights from NEJM Group:

NEJM Catalyst Innovations in Care Delivery: Conversation: Dr. Karthik Sivashanker, Medical Director for Quality, Safety, and Equity at Brigham and Women's Hospital in Boston, describes how his organization has woven equity and anti-racism efforts into their already well-established quality and safety procedures.

NEJM Journal Watch Cardiology: In an observational matched cohort study among patients with acute coronary syndrome, net adverse clinical events did not differ between ticagrelor and clopidogrel users — a finding that contrasts with an older, large, randomized trial.

NEJM CareerCenter:

• Oncology/hematology: MaineHealth Cancer Care is seeking oncologist/hematologists to join its rapidly growing practice network in Maine.

• OB/GYN: Signature Healthcare in Easton, Massachusetts — just 25 miles from Boston — is seeking an OB/GYN.